The FDA will review both Medicis Pharmaceutical Corp.'s Restylane and Inamed Corp's Hylaform on November 21.
Dermal Infusions and Injections Lead to Improved Skin Quality
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
The Weekly Roundup: March 27-31
The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition
What's Trending in Skin Care: March 2023
Treating Dermatological Conditions by Going Beyond the Skin